DiBiase Mary, COO of X4 Pharmaceuticals XFOR, has filed 0 purchases and 12 sales on the open market. The latest trade was on 25/02/12.

DM

DM

DiBiase Mary

COO

Company

X4 Pharmaceuticals XFOR

First filing

23/02/15

Trades

17 trades

Buys / sales

0 / 12

12-month net buying

No record

Last trade

25/02/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
X4 PharmaceuticalsXFOR	Open-market sale	25/01/24	25/01/27	22,258 sh	$0.45	$10,016.1	−4.3%
X4 PharmaceuticalsXFOR	Open-market sale	24/10/07	24/10/08	67,695 sh	$0.57	$38,586.15	−13.0%
X4 PharmaceuticalsXFOR	Open-market sale	24/09/09	24/09/11	2,642 sh	$0.66	$1,743.72	−0.9%
X4 PharmaceuticalsXFOR	Open-market sale	24/03/11	24/03/11	15,409 sh	$0.88	$13,559.92	−5.0%
X4 PharmaceuticalsXFOR	Open-market sale	24/02/12	24/02/12	3,683 sh	$1.01	$3,719.83	−1.2%
X4 PharmaceuticalsXFOR	Open-market sale10b5-1 plan	23/11/01	23/11/03	67,695 sh	$0.73	$49,417.35	−17.9%
X4 PharmaceuticalsXFOR	Open-market sale	23/09/08	23/09/12	2,642 sh	$1.25	$3,302.5	−1.8%
X4 PharmaceuticalsXFOR	Open-market sale	23/06/30	23/07/05	464 sh	$1.89	$876.96	−0.3%
X4 PharmaceuticalsXFOR	Open-market sale	23/06/23	23/06/26	857 sh	$1.93	$1,654.01	−0.6%
X4 PharmaceuticalsXFOR	Open-market sale	23/06/15	23/06/16	857 sh	$2.23	$1,911.11	−0.6%
X4 PharmaceuticalsXFOR	Open-market sale	23/03/10	23/03/13	18,192 sh	$0.84	$15,281.28	−10.6%
X4 PharmaceuticalsXFOR	Open-market sale	23/02/13	23/02/15	4,348 sh	$0.93	$4,043.64	−2.5%